SANOFI (SAN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
82.72 EUR
-0.28 (-0.34%)
We assign a fundamental rating of 5 out of 10 to SAN. SAN was compared to 52 industry peers in the Pharmaceuticals industry. While SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SAN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SAN had positive earnings in the past year.
SAN had a positive operating cash flow in the past year.
Each year in the past 5 years SAN has been profitable.
SAN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SAN's Return On Assets of 11.05% is amongst the best of the industry. SAN outperforms 80.77% of its industry peers.
SAN has a Return On Equity of 19.73%. This is in the better half of the industry: SAN outperforms 69.23% of its industry peers.
SAN's Return On Invested Capital of 13.84% is fine compared to the rest of the industry. SAN outperforms 71.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 13.72%.
The 3 year average ROIC (7.31%) for SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
With an excellent Profit Margin value of 20.35%, SAN belongs to the best of the industry, outperforming 82.69% of the companies in the same industry.
SAN's Profit Margin has improved in the last couple of years.
SAN has a Operating Margin of 23.59%. This is in the better half of the industry: SAN outperforms 61.54% of its industry peers.
In the last couple of years the Operating Margin of SAN has grown nicely.
SAN has a Gross Margin (71.70%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SAN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SAN has about the same amount of shares outstanding.
SAN has a better debt/assets ratio than last year.
2.2 Solvency
SAN has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SAN would need 2.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, SAN belongs to the top of the industry, outperforming 82.69% of the companies in the same industry.
SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SAN has a Debt to Equity ratio of 0.21. This is in the better half of the industry: SAN outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.63%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SAN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, SAN is in line with its industry, outperforming 40.38% of the companies in the same industry.
SAN has a Quick Ratio of 1.27. This is a bad value and indicates that SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SAN (0.94) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
Measured over the past 5 years, SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 2.56% in the past year.
Measured over the past years, SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.11% on average over the next years.
SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.55% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.11%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.88 indicates a reasonable valuation of SAN.
Compared to the rest of the industry, the Price/Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 86.54% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. SAN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.73, the valuation of SAN can be described as very reasonable.
SAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 86.54% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. SAN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.88 | ||
| Fwd PE | 9.73 |
4.2 Price Multiples
69.23% of the companies in the same industry are more expensive than SAN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SAN is valued a bit cheaper than 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.95 | ||
| EV/EBITDA | 10.6 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.59
PEG (5Y)2.14
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
No dividends for SAN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:SAN (12/31/2025, 7:00:00 PM)
82.72
-0.28 (-0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap200.93B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target106.44 (28.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-1.94%
PT rev (3m)-3.01%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)0.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.88 | ||
| Fwd PE | 9.73 | ||
| P/S | 2.96 | ||
| P/FCF | 19.95 | ||
| P/OCF | 17.66 | ||
| P/B | 2.87 | ||
| P/tB | 21.62 | ||
| EV/EBITDA | 10.6 |
EPS(TTM)7.6
EY9.19%
EPS(NY)8.5
Fwd EY10.28%
FCF(TTM)4.15
FCFY5.01%
OCF(TTM)4.69
OCFY5.66%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)4.59
PEG (5Y)2.14
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SAN.PA FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SAN.PA) has a profitability rating of 7 / 10.
What is the valuation of SANOFI based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.88 and the Price/Book (PB) ratio is 2.87.
How financially healthy is SANOFI?
The financial health rating of SANOFI (SAN.PA) is 5 / 10.